Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Studies Showing the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists In addition to lowering HbA1c, GLP-1 RAs improve traditional cardiovascular disease risk factors such as obesity and hypertension, whilst also exerting anti-inflammatory and anti-atherosclerotic effects, and having positive direct modulatory effects on endothelial function
Rare, more severe side effects can occur, and its critical to seek immediate medical attention if these arise
Both options are especially helpful for people who struggle with appetite regulation or emotional/behavioral eating patterns
Mechanism of action: Semaglutide mimics the action of the natural hormone GLP-1, stimulating insulin when blood sugar is high and reducing the release of glucagon (which raises blood sugar)
